Distinguished Chair Professor and Dean
College of Pharmaceutical Sciences, Zhejiang University
Director of the National Key Laboratory of the Advanced Drug Delivery and Release Systems
Group Website:
Dr. Zhen Gu is a Qiushi Distinguished Chair Professor and Dean of College of Pharmaceutical Sciences at Zhejiang University. He also serves as the Director of the National Key Laboratory of the Advanced Drug Delivery and Release Systems. Dr. Gu received his B.S. degree in Chemistry and M.S. degree in Polymer Chemistry and Physics from Nanjing University. In 2010, he obtained Ph.D. from the Department of Chemical and Biomolecular Engineering at UCLA. He was a Postdoctoral Associate working with Dr. Robert Langer at MIT and Harvard Medical School during 2010 to 2012. Before he moved to Zhejiang University in 2020, he was a Full Professor in the Department of Bioengineering and Director of the NIH Biotechnology Training in Biomedical Sciences and Engineering Program at UCLA. From 2012 to 2018, he was working in the Joint Department of Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University, where he had been appointed as a Jackson Family Distinguished Professor. Dr. Gu's group studies controlled drug delivery, biomaterials and cell therapy. He has published over 240 research papers and applied over 150 patents. He is the recipient of the Felix Franks Medal of the Royal Society of Chemistry (2020), Young Investigator Award of Controlled Release Society (2017), Sloan Research Fellowship (2016) and Pathway Award of the American Diabetes Association (2015). MIT Technology Review listed him in 2015 as one of the top innovators under the age of 35. He was elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) in 2019 and the International Academy of Medical and Biological Engineering (IAMBE) in 2021. Dr. Gu serves as an Associate Editor for Science Advances, Nano Research and Regenerative Biomaterials.
Representative Publications
[1] J. Zhang, X. Wei, W. Liu, Y. Wang, A. R. Kahkoska, X. Zhou, H. Zheng, W. Zhang, T. Sheng, Y. Zhang, Y. Liu, K. Ji, Y. Xu, P. Zhang, J. Xu, J. B. Buse, J. Wang*, Z. Gu*, Week-long Norm Glycaemia in Diabetic Mice and Minipigs via A Subcutaneous Dose of A Glucose-responsive Insulin Complex, Nat. Biomed. Eng., in press, 2023.
[2] Q. Hu+, H. Li+, E. Ogunnaike, Q. Chen, H. Ruan, S. Ahn, E. Dukhovlinova, K. Yang, D. Wen, G. Dotti*, Z. Gu*, Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets, Nat. Biomed. Eng., 5, 1038, 2021.
[3] Z. Chen+, H. Li+, Y. Bian, Z. Wang, G. Chen, X. Zhang, Y. Miao, D. Wen, J. Wang, G. Wan, Y. Zeng, P. Abdou, J. Fang, S. Li, C. Sun, Z. Gu*, Bioorthogonal catalytic patch, Nat. Nanotechnol., 16(933), 2021.
[4] J. Yu, J. Wang, Y. Zhang, G. Chen, W. Mao, Y. Ye, A. R. Kahkoska, J. B. Buse, R. Langer, Z. Gu*, Glucose-Responsive Insulin Patch for the Regulation of Blood Glucose Regulation in Mice and Minipigs, Nat. Biomed. Eng., 4, 499, 2020. (Cover Feature)
[5] Q. Chen, C. Wang, X. Zhang, G. Chen, Q. Hu, H. Li, J. Wang, D. Wen, Y. Zhang, G. Yang, Y. Lu, C. Jiang, G. Dotti, J. Wang, Z. Gu*, In situ Sprayed Bioresponsive Immunotherapeutic Gel for Post-Surgical Cancer Treatment, Nat. Nanotechnol., 14, 89, 2019. (Cover Feature)
